Peritoneal autoantibody profiling identifies p53 as an autoantibody target in endometriosis

被引:2
|
作者
Harden, Sarah [1 ,2 ,3 ]
Tan, Tse Yeun [4 ,5 ]
Ku, Chee Wai [4 ,5 ]
Zhou, Jieliang
Chen, Qingfeng [3 ]
Chan, Jerry Kok Yen [4 ,5 ]
Brosens, Jan [2 ,7 ,8 ]
Lee, Yie Hou [1 ,5 ,6 ,9 ,10 ]
机构
[1] Singapore MIT Alliance Res & Technol, Crit Analyt Mfg Precis Med, Singapore, Singapore
[2] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Clin Sci Res Labs, Coventry, England
[3] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore
[4] KKH, Dept Reprod Med, Singapore, Singapore
[5] Duke NUS Med Sch, Acad Clin Program, OBGYN, Singapore, Singapore
[6] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore
[7] Univ Hosp Coventry & Warwickshire, Tommys Natl Ctr Miscarriage Res, Coventry, England
[8] Univ Warwick, Ctr Early Life, Warwick Med Sch, Coventry, England
[9] Singhealth Duke NUS Acad Med, OBGYN ACP, 100 Bukit Timah Rd, Singapore 229899, Singapore
[10] Singapore MIT Alliance Res & Technol, 1 CREATE Way,04-13-14 Enterprise Wing, Singapore 138602, Singapore
基金
英国惠康基金; 英国医学研究理事会;
关键词
Endometriosis; autoantibodies; autoimmunity; peritoneal; p53; TUMOR-SUPPRESSOR; AUTOIMMUNE; WOMEN; ANTIBODIES; EXPRESSION; OVARIAN; CANCER; OVEREXPRESSION; CITRULLINATION; GLYCOPROTEIN;
D O I
10.1016/j.fertnstert.2023.02.025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To map the peritoneal autoantibody (AAb) landscape in women with endometriosis.Design: Case-control laboratory study. Setting: Academic medical and research units.Patient(s): Women who presented with or without endometriosis. Intervention(s): None.Main Outcome Measure(s): Using native-conformation and citrullinated modified protein arrays, proteome-wide analysis of AAbs against 1,623 proteins were profiled in peritoneal fluids (PFs) of 25 women with endometriosis and 25 women without endometriosis.Result(s): In women with endometriosis, the median number of AAbs detected was 4, including AAbs that targeted autoantigens involved in implantation, B-cell activation/development, and aberrant migration and mitogenicity. Forty-six percent of women with endometriosis have R5 peritoneal AAbs. Conversely, in women without endometriosis, the median number of detected AAbs was 1. Autoantibodies recognizing tumor suppressor protein p53 were the most commonly detected AAbs, being present in 35% of women with endometriosis, and p53 AAb was associated with a monocyte/macrophage-like PF cytokine signature. Further investigation of the global reactivity of AAbs against citrullinated PF antigens by peptidylarginine deiminase enzymes 1, 2, and 6 revealed anticitrullinated p53 as the only AAb target elevated and citrullinated by all 3 peptidylarginine deiminase isotypes. Furthermore, unsupervised hierarchical clustering and integrative pathway analysis revealed that 60% of women with endometriosis-associated infertility were positive for AAbs, which are involved in platelet-derived growth factor, transforming growth factor -b, RAC1/PAK1/ p38/MMP2 signaling, LAT2/NTAL/LAB-mediated calcium mobilization, and integrin-mediated cell adhesion.Conclusion(s): Together, our data identify peritoneal autoimmunity in a significant subset of women with endometriosis, with impli-cations on infertility and disease pathophysiology. In these patients, p53 was identified as the most frequent PF AAb target, which was present in both the native and citrullinated forms. (Fertil Steril & REG; 2023;120:176-87. & COPY;2023 by American Society for Reproductive Med-icine.) El resumen esta disponible en Espanol al final del articulo.
引用
收藏
页码:176 / 187
页数:12
相关论文
共 50 条
  • [21] p53 as a target for the treatment of cancer
    Duffy, Michael J.
    Synnott, Naoise C.
    McGowan, Patricia M.
    Crown, John
    O'Connor, Darran
    Gallagher, William M.
    CANCER TREATMENT REVIEWS, 2014, 40 (10) : 1153 - 1160
  • [22] Association of p53 codon 72 polymorphism with endometriosis
    Ammendola, Maria
    Gloria-Bottini, Fulvia
    Sesti, Francesco
    Piccione, Emilio
    Bottini, Egidio
    FERTILITY AND STERILITY, 2008, 90 (02) : 406 - 408
  • [23] Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation
    Vig, Saurabh
    Talwar, Puneet
    Kaur, Kirandeep
    Srivastava, Rohit
    Srivastava, Arvind K.
    Datta, Malabika
    CELL CYCLE, 2015, 14 (14) : 2274 - 2284
  • [24] Mutant p53 as a target for cancer treatment
    Duffy, Michael J.
    Synnott, Naoise C.
    Crown, John
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 258 - 265
  • [25] p53: An Attractive Therapeutic Target for Cancer
    Patel, Krupa R.
    Patel, Hitesh D.
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (22) : 3706 - 3734
  • [26] Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway
    Zou, Wen
    Wang, Xi
    Xia, Xiaomeng
    Zhang, Tingting
    Nie, Meifang
    Xiong, Jing
    Fang, Xiaoling
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 692
  • [27] An unusually aggressive case of endometriosis showing p53 expression
    Ismail, SM
    Vandeginste, S
    Shaw, RW
    JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (05) : 396 - 398
  • [28] Association of p53 and CDKN1A Genotypes with Endometriosis
    Ying, Tsung-Ho
    Tseng, Chih-Jen
    Tsai, Su-Ju
    Hsieh, Shu-Ching
    Lee, Hong-Zin
    Hsieh, Yi-Hsien
    Bau, Da-Tian
    ANTICANCER RESEARCH, 2011, 31 (12) : 4301 - 4306
  • [29] p53 as a therapeutic target
    Staples, O. D.
    Steele, R. J. C.
    Lain, S.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2008, 6 (04): : 240 - 243
  • [30] Current strategies to target p53 in cancer
    Chen, Fang
    Wang, Wenge
    El-Deiry, Wafik S.
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 724 - 730